Barely Significant
← all excerpts

Phase II Randomized Study of MK-2206 and Bicalutamide in Prostate Cancer Patients With Rising PSA After Primary Therapy (ECOG-ACRIN E2809).

Prostate · 2026 · PMC13185475 · PMID 41609418

Europe PMCDOI
1
hedged sentence
0.1300
closest p · 2.6× alpha
0.1300
boldest claim

The sentences

a possible trendp = 0.13not close (p > 0.1)
Of note, there was a significant association of prior ADT given with XRT and the incidence of PD during the PreBic phase (PBPD) on arm A ( p = 0.008) and a possible trend toward this association on arm B ( p = 0.13; Table S2 ).

also in 1,410 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.